These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6383500)

  • 1. A study of the kinetics of ADP-triggered platelet shape change.
    Hantgan RR
    Blood; 1984 Oct; 64(4):896-906. PubMed ID: 6383500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
    Milton JG; Frojmovic MM
    J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of the morphological reaction of platelets to aggregating agents and of its reversal by aggregation inhibitors.
    Born GV; Dearnley R; Foulks JG; Sharp DE
    J Physiol; 1978 Jul; 280():193-212. PubMed ID: 99512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets interact with fibrin only after activation.
    Hantgan RR; Taylor RG; Lewis JC
    Blood; 1985 Jun; 65(6):1299-311. PubMed ID: 3888311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of ADP-induced human platelet shape change: apparent positive cooperativity.
    Milton JG; Yung W; Glushak C; Frojmovic MM
    Can J Physiol Pharmacol; 1980 Jan; 58(1):45-52. PubMed ID: 6991077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the kinetics and mechanism of ADP-triggered platelet aggregation.
    Hantgan RR
    Biochim Biophys Acta; 1985 Jul; 846(1):64-75. PubMed ID: 4016157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses to adenosine diphosphate in human platelets loaded with the fluorescent calcium indicator quin2.
    Hallam TJ; Rink TJ
    J Physiol; 1985 Nov; 368():131-46. PubMed ID: 4078739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient kinetics of the rapid shape change of unstirred human blood platelets stimulated with ADP.
    Deranleau DA; Dubler D; Rothen C; Lüscher EF
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7297-301. PubMed ID: 6961409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of myosin light-chain kinase in platelet shape change and aggregation.
    Hashimoto Y; Sasaki H; Togo M; Tsukamoto K; Horie Y; Fukata H; Watanabe T; Kurokawa K
    Biochim Biophys Acta; 1994 Sep; 1223(2):163-9. PubMed ID: 8086484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antiplatelet antibody on platelet shape change, volume, and morphology.
    Colman RW; Nachmias VT; Cines DB; Schreiber AD
    Am J Physiol; 1983 Mar; 244(3):H357-61. PubMed ID: 6829777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface morphology of human platelets during in vitro aggregation.
    Zilla P; Groscurth P; Rhyner K; von Felten A
    Scand J Haematol; 1984 Nov; 33(5):440-7. PubMed ID: 6515327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
    Pearce PH; Wright JM; Egan CM; Scrutton MC
    Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light scattering changes of edetic acid-treated, washed rat platelets: effect of adenosine diphosphate and calcium ion in relation to chilling.
    Shibata S; Kobayashi B
    Thromb Diath Haemorrh; 1975 Jun; 33(3):508-18. PubMed ID: 239458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-range interactions in mammalian platelet aggregation. II. The role of platelet pseudopod number and length.
    Frojmovic M; Longmire K; van de Ven TG
    Biophys J; 1990 Aug; 58(2):309-18. PubMed ID: 2207239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets in essential hypertension.
    Nityanand S; Pande I; Bajpai VK; Singh L; Chandra M; Singh BN
    Thromb Res; 1993 Dec; 72(5):447-54. PubMed ID: 8303687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of ADP-induced fibrinogen binding to platelet shape change and aggregation elucidated by use of colchicine and cytochalasin B.
    Peerschke EI; Zucker MB
    Thromb Haemost; 1980 Feb; 43(1):58-60. PubMed ID: 7404479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-specific desensitization of shape change of platelets.
    Saito Y; Imada T; Shimada H; Kikuchi T; Suzuki H; Yamazaki H; Inada Y
    Thromb Res; 1984 Sep; 35(6):689-95. PubMed ID: 6506024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.